ArticleMolecular oncology2023

Histone-lysine N-methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc-driven liver cancer.

Dexter Kai Hao Thng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.